Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study

被引:14
|
作者
Huang, Chun-Jui [1 ,2 ]
Chen, Po-Ju [1 ]
Chang, Jing-Wen [3 ]
Huang, De-Feng [2 ,4 ]
Chang, Shih-Lin [2 ,5 ]
Chen, Shih-Ann [2 ,5 ]
Jap, Tjin-Shing [1 ,2 ]
Lin, Liang-Yu [1 ,2 ,6 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan
[2] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan
[3] Kaohsiung Armed Forces Gen Hosp, Dept Med, Kaohsiung, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan
[6] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan
关键词
Amiodarone; Hypothyroidism; Thyrotoxicosis; CONGENITAL HEART-DISEASE; INDUCED THYROTOXICOSIS; INDUCED HYPOTHYROIDISM; FOLLOW-UP; RISK-FACTORS; MANAGEMENT; PREDICTABILITY; COMMUNITY; DIAGNOSIS; THERAPY;
D O I
10.1007/s11096-013-9910-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background The incidence and risk factors of amiodarone-induced thyroid dysfunction are variable in the literature. Objective The aim of this study was to investigate the clinical and biochemical features and risk factors of amiodarone-induced thyroid dysfunction in Taiwan. Setting This study was conducted at a tertiary referral center for arrhythmia. Method Retrospective analysis of patients treated with amiodarone during the years 2008-2009 was performed. Main outcome measure Incidence and risk factors of amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH) were assessed. Results Of the 527 patients, 437 (82.9 %) remained euthyroid, 21 (4.0 %) developed AIT, and 69 (13.1 %) were affected with AIH. In univariate analysis, AIT was associated with younger age, and the risk factors for AIH included older age, higher baseline thyroid stimulating hormone (TSH) titer, lower baseline free T4 level, lower cumulative amiodarone dosage, and shorter amiodarone treatment duration. Cox regression analysis was performed to determine the different risk categories in the elderly population of age 65-74 (young-old), 75-84 (old-old), and a parts per thousand yen85 years old (oldest-old). Additionally increased risk of AIH was found in the groups of old-old (HR 2.09, 95 % CI 1.11-3.96) and oldest-old (HR 2.57, 95 % CI 1.21-4.75). In the multivariate analysis of risk factors for AIH, baseline TSH level (HR 1.38, 95 % CI 1.12-1.70) and cumulative amiodarone dosage (HR 0.95, 95 % CI 0.93-0.97) remained statistically significant. Conclusion AIH was much more common than AIT in Taiwan, an area with sufficient iodine intake. Higher baseline TSH level was the predominant independent risk factor for the development of AIH.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 50 条
  • [21] Prediction of amiodarone-induced thyroid dysfunction in those with normal baseline thyroid function: A retrospective analysis of 288 patients
    Kum, LEOC
    Fung, JWH
    So, WY
    Chan, WL
    Woo, KS
    Yu, CM
    Sanderson, JE
    EUROPEAN HEART JOURNAL, 2003, 24 : 516 - 516
  • [22] Amiodarone-induced thyroid disorders
    Trummer, Christian
    Theiler-Schwetz, Verena
    Pilz, Stefan
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2020, 13 (03): : 119 - 123
  • [23] Amiodarone-Induced Thyorid Dysfunction
    Meyer, Frank P.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (14): : 263 - 263
  • [24] Amiodarone-induced ocular and extra-ocular toxicity: a retrospective cohort study
    Dammacco, Rosanna
    Guerriero, Silvana
    Cardia, Giuseppina
    Alessio, Giovanni
    Vacca, Angelo
    Dammacco, Franco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [25] Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction
    Mikie Yamato
    Kyoichi Wada
    Mai Fujimoto
    Kouichi Hosomi
    Tomohiro Hayashi
    Akira Oita
    Mitsutaka Takada
    European Journal of Clinical Pharmacology, 2017, 73 : 289 - 296
  • [26] Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction
    Yamato, Mikie
    Wada, Kyoichi
    Fujimoto, Mai
    Hosomi, Kouichi
    Hayashi, Tomohiro
    Oita, Akira
    Takada, Mitsutaka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) : 289 - 296
  • [27] Explainable Machine Learning Techniques To Predict Amiodarone-Induced Thyroid Dysfunction Risk: Multicenter, Retrospective Study With External Validation
    Lu, Ya-Ting
    Chao, Horng-Jiun
    Chiang, Yi-Chun
    Chen, Hsiang-Yin
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [28] Clinical characteristics of seven Japanese patients with amiodarone-induced thyroid dysfunction
    Kanezaki, Yoshiko
    Miya, Keiko
    Nakai, You
    Kondo, Eri
    Shintani, Yasumi
    ENDOCRINE JOURNAL, 2010, 57 : S457 - S458
  • [29] Amiodarone-induced thyrotoxicosis in heart failure with a reduced ejection fraction: A retrospective cohort study
    Yamamoto, Jennifer M.
    Katz, Pamela M.
    Bras, James A. F.
    Shafer, Leigh Anne
    Leung, Alexander A.
    Ravandi, Amir
    Cordova, Francisco J.
    HEALTH SCIENCE REPORTS, 2018, 1 (05)
  • [30] Amiodarone-induced thyroid gland dysfunctions
    Gassanov, N.
    Dietlein, M.
    Caglayan, E.
    Erdmann, E.
    Er, F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (16) : 807 - 811